Lövgren Anna, Vallin Simon, Häggman-Henrikson Birgitta, Kapos Flavia P, Peck Christopher C, Visscher Corine M, Liv Per
Department of Odontology/Orofacial Pain and Jaw Function, Faculty of Medicine, Umeå University, 901 87, Umeå, Sweden.
Department of Orofacial Pain and Jaw Function, Malmö University, Malmö, Sweden.
Sci Rep. 2025 Feb 8;15(1):4732. doi: 10.1038/s41598-025-86502-0.
Decision-making for temporomandibular disorders (TMDs) is reported being a clinical challenge, partly due to uncertainities in assessment of long-term prognosis. Therefore, our aim was to explore variations over time in TMD symptoms and possible sex or age differences. In this cohort study, data were prospectively collected 2010-2017 from the general population in Västerbotten, Northern Sweden. Adults were eligible if they had undergone at least two routine dental check-ups that included screening for TMDs (3Q/TMD) from which states were defined as absence or presence of TMD pain and/or jaw catching/locking. The rate of transitions was estimated between TMD states within a time span of one year. A total of 94,769 individuals were included (49.9% women) with 205,684 repeated visits and 9,006 state transitions recorded over the 8-year period. Compared to men, women had higher rates of transitions from no TMDs to any TMD symptoms. Furthermore, women had a lower rate of transition from TMD pain only to no TMDs. The finding of a poorer prognosis in women, as well as previously reported potential gender differences in pain perception and reporting, reinforces that gender differences should be accounted for in the treatment planning stage for patients with onset of TMDs.
据报道,颞下颌关节紊乱病(TMDs)的决策是一项临床挑战,部分原因是长期预后评估存在不确定性。因此,我们的目的是探讨TMD症状随时间的变化以及可能存在的性别或年龄差异。在这项队列研究中,2010年至2017年前瞻性收集了瑞典北部韦斯特博滕郡普通人群的数据。如果成年人至少接受过两次包括TMD筛查(3Q/TMD)的常规牙科检查,则符合入选条件,TMD状态定义为是否存在TMD疼痛和/或颌部卡顿/锁定。在一年的时间跨度内估计了TMD状态之间的转变率。在8年期间,共纳入94,769人(49.9%为女性),进行了205,684次重复就诊,记录了9,006次状态转变。与男性相比,女性从无TMD转变为出现任何TMD症状的比率更高。此外,女性从仅患有TMD疼痛转变为无TMD的比率较低。女性预后较差的这一发现,以及先前报道的疼痛感知和报告方面可能存在的性别差异,强化了在TMD发病患者的治疗规划阶段应考虑性别差异。